BackG Medical Innovations Holdings Limited Overview

G Medical Innovations Holdings Limited Total Liabilities

Latest total liabilities for GMVD: $9.4M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$9.40M
29.51% YoYΔ $-3.93M vs prior year quarter

Peer trimmed avg / median

Loading

G Medical Innovations Holdings Limited Total Liabilities History

Loading

G Medical Innovations Holdings Limited vs. peers: Total Liabilities Comparison

Loading

G Medical Innovations Holdings Limited Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

G Medical Innovations Holdings Limited (GMVD) FAQ

G Medical Innovations Holdings Limited's total liabilities stands at $9.4M as of December 2022. That compares with $13M in the prior-year period — down 29.5% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

G Medical Innovations Holdings Limited reported $9.4M in total liabilities versus $13M a year earlier — a 29.5% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $13M in the prior-year period — down 29.5% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how G Medical Innovations Holdings Limited's total liabilities evolved across reporting periods, while the comparison chart places GMVD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total liabilities is commonly used to spot outliers. G Medical Innovations Holdings Limited's reading of $9.4M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.